Real-world cost analysis of amlodipine/valsartan versus angiotensin receptor blocker + calcium channel blockers in USA.
Phase of Trial: Phase IV
Latest Information Update: 28 May 2013
Price : $35 *
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Angiotensin receptor antagonists; Calcium channel antagonists
- Indications Cardiovascular disorders; Hypertension
- Focus Therapeutic Use
- 28 May 2013 New trial record
- 18 May 2013 Results presented at the 28th Annual Scientific Meeting of the American Society of Hypertension.